Skip to main content

Table 7 Comparison of polypnea scores before and after treatment

From: Therapeutic effect of subcutaneous injection of low dose recombinant human granulocyte-macrophage colony-stimulating factor on pulmonary alveolar proteinosis

(A): Changes of polypnea scores before treatment and after 6 months of treatment (n = 20)

Scores before treatment

Scores after 6 months of treatment

Number of cases

1

1

4

2

1

4

3

1

4

3

2

3

4

1

4

5

1

1

(B): Changes of polypnea scores before treatment and after 12 months of treatment (n = 17)

Scores before treatment

Scores after 12 months of treatment

Number of cases

1

0

1

1

1

2

2

0

1

2

1

1

2

3

1

3

0

2

3

1

3

3

2

1

3

3

1

4

1

3

5

1

1

  1. The score of polypnea was also improved before and after 6 months of treatment, with significant difference (z = 3.562, P = 0.000011). Seventeen patients were followed up after 12 months, and compared with that before treatment, the polypnea after 12 months of treatment was also improved, with statistically significant difference (z = 3.830, P = 0.000128)